Publication dates

Carcinoma Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, microbiology, more »


 
1-10 of 89 reports for Carcinoma

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Targeted for various forms of cancer such as breast cancer (mcf-7/mdr), small-cell lung cancer (h69ar), uterine carcinoma (mes-sa/dx5) and pancreatic cancer (panc-1). The company also offers difluoro ...

 Adrenocortical Carcinoma (Adrenal Cortex Cancer)-Pipeline Insights, 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under adrenocortical carcinoma (adrenal ...

 Basal Cell Carcinoma-Pipeline Insights, 2014

Basal Cell Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under basal cell carcinoma. This report provides information on the therapeutic development ...

 Basal Cell Carcinoma (Basal Cell Epithelioma)-Pipeline Insights, 2014

Basal Cell Carcinoma (Basal Cell Epithelioma)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under basal cell carcinoma (basal cell ...

 Colon Carcinoma-Pipeline Insights, 2014

Colon Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under colon carcinoma. This report provides information on the therapeutic development based ...

 Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2014

Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under gastroesophageal (ge) junction carcinomas ...

 Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014

Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Reasons to buy - complete pipeline intelligence and complete understanding over therapeutics development for head and neck cancer squamous cell carcinoma - identify the relationship between the drugs ...

 Metastatic Hepatocellular Carcinoma (HCC)-Pipeline Insights, 2014

Metastatic Hepatocellular Carcinoma (HCC)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under metastatic hepatocellular carcinoma (hcc ...

 Metastatic Renal Cell Carcinoma-Pipeline Insights, 2014

Metastatic Renal Cell Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under metastatic renal cell carcinoma. This report provides ...

 Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2014

Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under neuro endocrine (carcinoid) carcinoma ...

About 2 200 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Pakistan and United Arab Emirates

  • Demographic Review, Clinical and Histological Presentation of Pa...
  • January 2012
    3 pages
  • Cancer  

    Carcinoma  

  • Pakistan  

    United Arab Emi...  

View report >

9 Companies for Carcinoma

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

Lilly and Co.

United States

Pfizer Inc.

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.